Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Alexander Shao"'
Publikováno v:
BMJ Open, Vol 14, Iss 11 (2024)
Objectives Randomised trials for the management of drug-resistant infections are challenging to conduct as target patient populations often lack decision-making capacity, and enrolment windows are typically short. Improving informed consent and risk
Externí odkaz:
https://doaj.org/article/671ed73738c349be827963ba07f48cc8
Autor:
Pang, Alexander Shao-Rong1 (AUTHOR) alexandersrp@u.nus.edu, Dinesh, Tarini2 (AUTHOR) tarinidinesh@gmail.com, Pang, Natalie Yan-Lin1 (AUTHOR) natalieylpang@gmail.com, Dinesh, Vishalli3 (AUTHOR) vishallidinesh@gmail.com, Pang, Kimberley Yun-Lin4 (AUTHOR) pang.kimmy@gmail.com, Yong, Cai Ling1 (AUTHOR) cailing2002@gmail.com, Lee, Shawn Jia Jun4 (AUTHOR) shawnleejiajun@hotmail.com, Yip, George W.5 (AUTHOR) antyipg@nus.edu.sg, Bay, Boon Huat5 (AUTHOR) antbaybh@nus.edu.sg, Srinivasan, Dinesh Kumar5 (AUTHOR) dineshkumar@nus.edu.sg
Publikováno v:
Molecules. Jun2024, Vol. 29 Issue 12, p2873. 26p.
Autor:
Alexander Shao‐Rong Pang, Vishalli Dinesh, Natalie Yan‐Lin Pang, Tarini Dinesh, Kimberley Yun‐Lin Pang, George W. Yip, Boon Huat Bay, Dinesh Kumar Srinivasan
Publikováno v:
Nano Select, Vol 5, Iss 3, Pp n/a-n/a (2024)
Abstract Myocardial infarction (MI) is the most prevalent non‐communicable disease worldwide. Nanotheranostics have made significant progress in the biomedical field, presenting an avenue to overcome the limitations of conventional approaches towar
Externí odkaz:
https://doaj.org/article/d27630dd5306437dab485faa7525433f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pang, Alexander Shao-Rong, Liau, Zi Qiang Glen, Oh, Jacob Yoong-Leong, Srinivasan, Dinesh Kumar
Publikováno v:
Journal of Nanotheranostics; Dec2024, Vol. 5 Issue 4, p167-187, 21p
Autor:
Alexander Shao-Rong Pang, Tarini Dinesh, Natalie Yan-Lin Pang, Vishalli Dinesh, Kimberley Yun-Lin Pang, Cai Ling Yong, Shawn Jia Jun Lee, George W. Yip, Boon Huat Bay, Dinesh Kumar Srinivasan
Publikováno v:
Molecules, Vol 29, Iss 12, p 2873 (2024)
Atherosclerosis continues to be a leading cause of morbidity and mortality globally. The precise evaluation of the extent of an atherosclerotic plaque is essential for forecasting its likelihood of causing health concerns and tracking treatment outco
Externí odkaz:
https://doaj.org/article/201cf39dbe8c42dab9d27a13653f8c86
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
Publikováno v:
Military Medical Research, Vol 8, Iss 1, Pp 1-17 (2021)
Abstract SARS-CoV-2 is a newly identified member of the coronavirus family that has caused the Coronavirus disease 2019 (COVID-19) pandemic. This rapidly evolving and unrelenting SARS-CoV-2 has disrupted the lives and livelihoods of millions worldwid
Externí odkaz:
https://doaj.org/article/cc27f986bb76497594a029730f383e62
Autor:
Trevor Y. H. Ho, Alexander Shao, Zeyu Lu, Harri Savilahti, Filippo Menolascina, Lei Wang, Neil Dalchau, Baojun Wang
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Split inteins are powerful tools for designing synthetic split proteins. Here the authors use a mini-Mu transposon screen to map split sites, enabling the development of protein-based logic gates and fine control of protein activity.
Externí odkaz:
https://doaj.org/article/4b896aa452b543a29fce64b160991170
Autor:
Pang, Alexander Shao‐Rong, Dinesh, Vishalli, Pang, Natalie Yan‐Lin, Dinesh, Tarini, Pang, Kimberley Yun‐Lin, Yip, George W., Bay, Boon Huat, Srinivasan, Dinesh Kumar
Publikováno v:
Nano Select; Mar2024, Vol. 5 Issue 3, p1-16, 16p
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
Publikováno v:
Military Medical Research, Vol 8, Iss 1, Pp 1-17 (2021)
Military Medical Research
Military Medical Research
SARS-CoV-2 is a newly identified member of the coronavirus family that has caused the Coronavirus disease 2019 (COVID-19) pandemic. This rapidly evolving and unrelenting SARS-CoV-2 has disrupted the lives and livelihoods of millions worldwide. As of